聚磷酸酯的合成及在生物医用材料中的应用

聚磷酸酯是一类主链通过磷酸酯键连接结构单元的高分子材料,由于其具有良好的生物相容性、生物可降解性和可功能化修饰等优点,逐渐引起研究者的关注,尤其在生物医用材料领域具有广泛的应用前景。本文首先对聚磷酸酯的合成方法(缩聚法、加成聚合法、烯烃复分解聚合法及开环聚合法)进行综述,在此基础上进一步介绍聚磷酸酯在药物载体、基因载体和组织工程等生物医用材料领域的应用,并对其发展前景进行展望。     

不饱和聚磷酸酯的合成及释药性能

不饱和聚磷酸酯的合成及释药性能;不饱和聚磷酸酯(UPPE);富马酸二（丙二醇）酯;生物材料;药物缓释;环丙沙星     

聚乙醇酸类生物降解高分子

聚乙醇酸类生物降解高分子具有良好的生物相容性,在药物缓释材料、组织工程材料、手术缝合线等医用领域有广泛的应用。文章按聚乙醇酸类生物降解高分子的种类不同,介绍了它们的合成、性能与应用,尤其是乙醇酸-乳酸共聚物的研究进展。展望聚乙醇酸类生物降解高分子的未来,降低合成成本是广泛应用的关键,因此简单易行的、以乙醇酸等单体为原料的直接缩聚法合成值得关注。     

聚磷酸酯—聚氨酯药物释放材料的合成

报道了一类新型生物可降解和生物相容性药物释放材料聚磷酸酯－聚氨酯的合成和表征，研究了这类聚合物的体外降解及其对牛血清白蛋白的释放性能。     

生物可降解聚磷酸酯的合成及其释药性能研究

生物可降解聚磷酸酯的合成及其释药性能研究罗毅，卓仁禧，范昌烈（武汉大学化学系，武汉，４３００７２）关键词聚磷酸酯，５－氟尿嘧啶，药物控制释放高分子控制释放材料的研究、发展及其在药物制剂中的应用对提高药物的持续性和专一性研究产生了突破，通过控制释放材料...     

抗植入式高分子医用材料感染的研究进展

植入式高分子医用材料表面会粘附细菌形成生物膜引发生物材料相关的感染(BRI),给高分子医用材料的广泛应用提出了重大挑战.本文从BRI发生的机制入手,综述了通过高分子医用材料表面改性减少细菌粘附与使用抗菌素-生物材料体系两个方面来抵抗BRI发生的研究进展,重点阐述了局部抗菌药物缓释体系及纳米技术在抗菌药物缓释体系中的应用,并指出高分子前药控释体系的研究和应用是抗高分子医用材料感染的发展趋势.     

新型生物可降解医用高分子材料—聚酸酐

综述了新型生物的可降解医用高分子材料－聚酸酐的发展概况，包括聚酸酐的发展历史，分类，合成及应用，提出了今后的研究方向。     

聚乙二醇共聚对苯二甲酸丁二醇酯的合成及在生物材料中的应用

综述了聚醚酯热塑性弹性体聚忆二醇／聚对苯二甲酸丁二醇酯（PEG／PBT）的合成、组成与性能关系及其在组织工程和药物缓释体系等方面的应用研究进展。PEG／PBT是一类力学性能优良、可降解和生物相容性良好、极具应用潜力的生物材料。     

官能团化聚己内酯的制备及其生物应用

聚己内酯(PCL)是一种疏水的、半结晶的、可降解的脂肪族聚合物,其具有良好的生物相容性、药物透过性和机械性能,在药物缓释和组织工程领域得到了广泛的关注。由于其结晶性强,亲水性差,生物降解速度慢,限制了其在生物医用领域更广泛的应用。聚己内酯的官能团化可实现对聚酯材料亲疏水性、降解速率等物化性质的调节,同时,活性官能团的引入便于对PCL的进一步化学修饰,有利于拓宽聚己内酯类材料的生物医用领域。本文详细介绍在聚己内酯骨架引入侧基官能团的化学方法,并简要阐述了官能团化聚己内酯在生物医用材料领域的应用。     

天然-合成高分子生物杂化材料在生物医学领域中的应用

综述了天然—合成高分子生物杂化材料在生物医学领域中的应用，并分析了它作为组织工程基质和药物载体的优点，指出生物杂化材料是生物医用材料的发展趋势。     

Biomedical application of responsive ‘smart’ electrospun nanofibers in drug delivery system: A minireview

Electrospinning is a versatile method for producing continuous nanofibers. It has since become an easy and cost-effective technique in the manufacturing process and drawn keen interests in most biomedical field applications. Nanofibers have garnered great attention in nanomedicine due to their resemblance with the extracellular matrix (ECM). Like nanoparticles, its unique characteristics of higher surface-to-volume ratio and the tunability of the polymers utilizing nanofiber have increased the efficiency in encapsulation and drug-loading capabilities. Smart or “stimuli-responsive” polymers have shown particular fascination in controlled release, where their ability to react to minor changes in the environment, such as temperature, pH, electric field, light, or magnetic field, distinguishes them as intelligent. Polymers are a popular material for the design of drug delivery carriers; consequently, various types of drugs, including antiviral, proteins, antibiotics, DNA and RNA, are successfully encapsulated in the pH-dependent nanofibers with smart polymers which is a polymer that can respond to change such as pH change, temperature. In this minireview, we discuss applications of smart electrospun pH-responsive nanofibers in the emerging biomedical developments which includes cancer drug targeting, oral controlled release, wound healing and vaginal drug delivery.     

Nanofibers for Biomedical and Healthcare Applications

Unique features of nanofibers provide enormous potential in the field of biomedical and healthcare applications. Many studies have proven the extreme potential of nanofibers in front of current challenges in the medical and healthcare field. This review highlights the nanofiber technologies, unique properties, fabrication techniques (i.e., physical, chemical, and biological methods), and emerging applications in biomedical and healthcare fields. It summarizes the recent researches on nanofibers for drug delivery systems and controlled drug release, tissue‐engineered scaffolds, dressings for wound healing, biosensors, biomedical devices, medical implants, skin care, as well as air, water, and blood purification systems. Attention is given to different types of fibers (e.g., mesoporous, hollow, core‐shell nanofibers) fabricated from various materials and their potential biomedical applications.     

Microchips as Controlled Drug-Delivery Devices

Controlled-release systems are common in a number of product areas, including foods, cosmetics, pesticides, and paper. Microencapsulated systems, for example, are used for the release of flavors and vitamins in foods, fragrances in perfumes, and inks in carbonless copy paper. Controlled-release systems for drug delivery first appeared in the 1960s and 1970s. In the past three decades, the number and variety of controlled release systems for drug-delivery applications has increased dramatically. Many of these use polymers having particular physical or chemical characteristics such as biodegradability, biocompatibility, or responsiveness to pH or temperature changes. However, recent advances in the field of microfabrication have created the possibility of a new class of controlled-release systems for drug delivery, namely, that of small, programmable devices. Their small size, potential for integration with microelectronics, and ability to store and release chemicals on demand could make controlled-release microchips useful in a number of areas, including medical diagnostics, analytical chemistry, chemical detection, industrial process monitoring and control, combinatorial chemistry, microbiology, and fragrance delivery. More importantly, drug-delivery microchips resulting from this convergence of controlled release and microfabrication technologies may provide new treatment options to clinicians in their fight against disease.     

控制药物释放体系及其机理

药物控制释放是目前药物学发展的一个重要领域,用于药物控制释放的载体一般是高分子材料。本文主要介绍药物控制释放的种类、机理、高分子材料及其应用。     

Zero-order release formulations using a novel cellulose ester

New carboxymethylcellulose esters were developed with useful properties for oral dosage forms in drug delivery. Normally, commercial cellulose esters are used as the major excipients in oral dosage forms as a coating or a membrane. In applications involving compression tablets, cellulose esters are usually mixed with other more hydrophilic matrix components to facilitate dissolution of the active. In the present study, novel cellulose esters were single component matrix resins. Pharmaceutical actives were cryogenically ground as a physical blend or an amorphous blend with the polymer. Subsequently, tablets were made by direct compression using a single tablet press, or capsules were made by filling them with the ground material. Dissolution tests were completed on the solid dosage forms at pH 1.2, 4.5, 6.8 or 7.4 in a United States Pharmacopeia (USP) II device to determine the release profiles for up to 24 h. Carboxymethylcellulose esters provide an excellent matrix for controlling both the rate of release and the pH at which pharmaceutical actives release into the aqueous environment. When used in suitable quantities, dictated by the active of interest, carboxymethylcellulose acetate butyrate provided zero-order release over sustained time up to 24 h.     

The synthesis of cholest-5-ene-3beta-carboxylates and a comparison of their mesomorphic behaviour with isomeric cholesterol esters with a reversed ester linkage

The syntheses of seven esters of cholest-5-ene-3beta-carboxylic acid are reported and the melting points, transition temperatures and mesophase morphologies of the esters are compared with those of the isomeric 3beta-cholesterol compounds which have the ester link reversed. For the examples reported, the cholest-5-ene-3beta-carboxlates always have significantly lower melting points, but the differences in clearing temperatures for the two series of esters are usually much less. Several of the new compounds give an increased chiral nematic phase range and an intense selective reflection of light. They therefore represent a novel type of chiral nematic material for use in thermochromic applications.     

The synthesis of cholest-5-ene-3beta-carboxylates and a comparison of their mesomorphic behaviour with isomeric cholesterol esters with a reversed ester linkage

The syntheses of seven esters of cholest-5-ene-3beta-carboxylic acid are reported and the melting points, transition temperatures and mesophase morphologies of the esters are compared with those of the isomeric 3beta-cholesterol compounds which have the ester link reversed. For the examples reported, the cholest-5-ene-3beta-carboxlates always have significantly lower melting points, but the differences in clearing temperatures for the two series of esters are usually much less. Several of the new compounds give an increased chiral nematic phase range and an intense selective reflection of light. They therefore represent a novel type of chiral nematic material for use in thermochromic applications.     

含环糊精膜的制备与应用*

本文简要介绍了环糊精的结构和性质,环糊精具有外部亲水,内部疏水的特殊分子构型,在膜内引入环糊精或环糊精衍生物对膜的性能具有很大的影响。综述了环糊精及其衍生物膜在异构体分离、金属离子传递、药物控制释放、药物检测与分析、酯盐水解及其他领域等方面的应用,评述了环糊精在自组装分子管道方面的作用,最后对含环糊精膜的发展方向进行了展望。     

光聚合水凝胶及其在组织工程中的应用

水凝胶是一种亲水性聚合物网络,可以溶胀大量水,其物理性质接近软组织.光聚合与传统的聚合方法相比,具有反应速率快、反应条件缓和、反应放热低等特点.因此,光聚合水凝胶广泛应用于生物医学领域.本文介绍了光聚合水凝胶材料,并详细论述了光聚合水凝胶在药物释放体系、组织工程支架材料、细胞受控生长、细胞微囊化和可注射水凝胶等方面的应用.可以预见光聚合水凝胶作为生物材料在组织工程及再生医学领域中具有良好的应用前景.     

The Research on Intelligent Controlled DDS of Polymer Carrier

The intelligent controlled drug delivery systems (DDS) are a series of the preparations including microcapsules or nanocapsules composed of intelligent polymers and medication. The properties of preparations can change with the external stimuli, such as pH value, temperature,chemical substance, light, electricity and magnetism etc. According to this properties, the DDS can be intelligently controlled. This paper has reviemed research on syntheses and applications of intelligent controlled DDS of polymer carriers.Drug delivery system with pH stimuliThe volume of polymer hydrogel can change with the pH value of external environment. The sensitive polymer hydrogels to pH are often as carriers. The polymer hydrogel carrying medicine is especially suitable for taking orally. In order to protect medicine from losing activation, we enwrapped medicine into polymer hydrogel with acidic group. In the acidic environment of stomach,the volume of polymer hydrogel contracts because of the hydrogen bond. The medicine in the polymer hydrogel cannot disperse out. When it goes to the intestine of basic environment, the hydrogen bond will be broken, and the medicine can release.Drug delivery system with temperatureTemperature sensitive polymer hydrogel can change its volume with changing of environmental temperature. This kind of polymer hydrogel can be also used as a carrier of medicine. At a low temperature, the polymer chains form hydrogen bond with water to swell to let medicine disperse out from the hydrogel. On the other hand, the hydrogen bond will be broken and polymer chain will lose water to contract with temperature's increasing. And the medicine will not disperse out. For example,the poly(N-isopropylacrylamide)(PNIPAAm) is the hydrogel that is swelled at lower temperature and contracted at higher temperature. PNIPAAm has the lower critical solution temperature(LCST).We can adjust its LCST to control PNIPAAm hydrogel's swelling or contraction to let medicine release or not.Drug delivery system with other stimuliThe polymer carrier drug delivery system can be intelligently controlled with the stimuli of pH value and temperature. In addition, there are still some other stimuli for DDS. For example, DDS with light; DDS with electricity(or electric field); DDS with magnetism(magnetic field); DDS with chemical substance; etc. The characteristic of intelligent polymer carrier is based on P.J.Flory's gel-swelling theory. Intelligent polymer carrier DDS will be widely used in biological and medical fields.